Cargando…
An Algae-Made RBD from SARS-CoV-2 Is Immunogenic in Mice
Despite the current advances in global vaccination against SARS-CoV-2, boosting is still required to sustain immunity in the population, and the induction of sterilizing immunity remains as a pending goal. Low-cost oral immunogens could be used as the basis for the design of affordable and easy-to-a...
Autores principales: | Govea-Alonso, Dania O., Malla, Ashwini, Bolaños-Martínez, Omayra C., Vimolmangkang, Sornkanok, Rosales-Mendoza, Sergio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9607479/ https://www.ncbi.nlm.nih.gov/pubmed/36297410 http://dx.doi.org/10.3390/ph15101298 |
Ejemplares similares
-
Current Status and Perspective on the Use of Viral-Based Vectors in Eukaryotic Microalgae
por: Bolaños-Martínez, Omayra C., et al.
Publicado: (2022) -
Efficient Transient Expression of Recombinant Proteins Using DNA Viral Vectors in Freshwater Microalgal Species
por: Malla, Ashwini, et al.
Publicado: (2021) -
Production and Purification of LTB-RBD: A Potential Antigen for Mucosal Vaccine Development against SARS-CoV-2
por: Solis-Andrade, Karla I., et al.
Publicado: (2022) -
The Potential of Algal Biotechnology to Produce Antiviral Compounds and Biopharmaceuticals
por: Rosales-Mendoza, Sergio, et al.
Publicado: (2020) -
Insights into antioxidant activities and anti-skin-aging potential of callus extract from Centella asiatica (L.)
por: Buranasudja, Visarut, et al.
Publicado: (2021)